1. Walsh B.T., Kaplan A.S, Attia E., Carter J., Devlin M.J., Olmsted M., Pike K.M., Woodside B., Parides M.: Fluoxetine vs. Placebo to prevent relapse in anorexia nervosa: Primary outcome of drug on time to relapse in 93 weight restored subjects. Paper presented at the Eating Disorders Research Society, Toronto, September, 2005.
2. Vandereycken W.: Neuroleptics in the short-term treatment of anorexia nervosa: A double-blind placebo-controlled study with sulpiride. Br. J. Psychiatry, 144, 288–292, 1984.
3. Halmi K., Eckert E., LaDu T., Cohen J.: Anorexia nervosa: Treatment efficacy of cyproheptadine and amitriptyline. Arch. Gen. Psychiatry, 43, 177–181, 1986.
4. Kaye W.H., Weltzin T.E.: Serotonin activity in anorexia and bulimia nervosa: relationship to the modulation of feeding and mood. J. Clin. Psychiatry, 52, 41–48, 1991.
5. Frank G.K., Kaye W.H., Weltzin T.E., Perel J., Moss H., McConaha C, Pollice C: Altered response to meta-chlorophenylpiperazine in anorexia nervosa: support for a persistent alteration of serotonin activity after short-term weight restoration. Int. J. Eat. Disord., 30, 57–68, 2001.